US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cohen & Steers

76.99

-0.4400-0.57%

Post-market: 76.990.00000.00%18:47 EDT

Volume:113.03K

Turnover:8.72M

Market Cap:3.92B

PE:25.17

High:77.58

Open:76.50

Low:76.09

Close:77.43

Loading ...

Overview Company News Filings

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at 7th International Congress on Controversies in Fibromyalgia

Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers

Cassava Sciences Reports 2024 Financial Results and Provides Business Update

Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-05 in Alzheimer’s Disease Agitation Supporting NDA Submission

Press Release: Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development

Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results

Cohen & Steers Launches SICAV Short Duration Preferred Income Fund

Praxis Precision Medicines Provides Update on Essential3 and Corporate Update

Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)

Alumis Presents Additional Phase 1 Data at ACTRIMS Forum 2025 Supporting Potential of A-005 as First-in-Class CNS Penetrant TYK2 Inhibitor for Treatment of Neuroinflammatory and Neurodegenerative Diseases

Virpax Reports Positive Results in Human Study for its Molecular Envelope Technology

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

Cassava Sciences Licenses Simufilam Method of Treatment Patent

Cohen & Steers, Inc. (NYSE:CNS) Stock Goes Ex-Dividend In Just Three Days

Simply Wall St.

Silo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder Treatment

CNS Pharmaceuticals reports cash position of $14M as of February 26

CNS Pharmaceuticals Provides Update on Current Cash Position and NASDAQ Listing

ACCESS Newswire

Press Release: Taysha Gene Therapies Reports Full-Year 2024 Financial Results and Provides Corporate Update

Plus Therapeutics Advances Lead Drug Rhenium (186Re) Obisbemeda for Patients with Leptomeningeal Metastases

Cohen & Steers (NYSE:CNS) Is Paying Out A Larger Dividend Than Last Year

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CNS/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CNS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNS\",,,,,undefined,":{"symbol":"CNS","market":"US","secType":"STK","nameCN":"Cohen & Steers","latestPrice":76.99,"timestamp":1746561600000,"preClose":77.43,"halted":0,"volume":113034,"hourTrading":{"tag":"盘后","latestPrice":76.99,"preClose":76.99,"latestTime":"18:47 EDT","volume":4759,"amount":366402.67,"timestamp":1746571640628},"delay":0,"floatShares":27540413,"shares":50979157,"eps":3.05822,"marketStatus":"Not Yet Opened","change":-0.44,"latestTime":"05-06 16:00:00 EDT","open":76.5,"high":77.575,"low":76.0931,"amount":8719369.287899999,"amplitude":0.019139,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.05822,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746604800000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1092369600000,"exchange":"NYSE","adjPreClose":77.43,"dividendRate":0.031043,"preHourTrading":{"tag":"盘前","latestPrice":77.27,"preClose":77.43,"latestTime":"08:56 EDT","volume":11,"amount":845.55009,"timestamp":1746536184347},"postHourTrading":{"tag":"盘后","latestPrice":76.99,"preClose":76.99,"latestTime":"18:47 EDT","volume":4759,"amount":366402.67,"timestamp":1746571640628},"volumeRatio":0.759857,"impliedVol":0.1346,"impliedVolPercentile":0.064},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNS\",,,,,undefined,":{"symbol":"CNS","floatShares":27540413,"roa":"14.72%","roe":"30.76%","lyrEps":3.000753,"volumeRatio":0.759857,"shares":50979157,"dividePrice":2.39,"high":77.575,"amplitude":0.019139,"preClose":77.43,"low":76.0931,"week52Low":67.09,"pbRate":"7.73","psRate":"7.42","week52High":110.67,"institutionHeld":0.6018,"latestPrice":76.99,"eps":3.05822,"divideRate":0.031043,"volume":113034,"delay":0,"ttmEps":3.05822,"open":76.5,"prevYearClose":92.34,"prevWeekClose":78.46,"prevMonthClose":76.32,"prevQuarterClose":80.25,"fiveDayClose":77.13,"twentyDayClose":73.3,"sixtyDayClose":89},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CNS\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516662075","title":"Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at 7th International Congress on Controversies in Fibromyalgia","url":"https://stock-news.laohu8.com/highlight/detail?id=2516662075","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516662075?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:00","pubTimestamp":1741089600,"startTime":"0","endTime":"0","summary":"TNX-102 SL is a sublingual formulation of cyclobenzaprine designed for transmucosal delivery and durable activity in treating fibromyalgia. TNX-102 SL demonstrated statistically significant improvement in the primary endpoint of reduction in fibromyalgia pain in two double-blind randomized Phase 3 studies. FDA Prescription Drug User Fee Act  goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia. If approved by FDA, it would become the first member of a new class of non-opioid analgesic drugs for fibromyalgia and the first new drug for treating fibromyalgia in more than 15 years","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tonix-pharmaceuticals-presented-data-analyses-120000851.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TNXP","BK4583","BK4135","BK4139","CNS"],"gpt_icon":1},{"id":"2516624909","title":"Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2516624909","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516624909?lang=en_us&edition=fundamental","pubTime":"2025-03-04 17:03","pubTimestamp":1741078998,"startTime":"0","endTime":"0","summary":"Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Bristol-Myers Squibb  and the best and worst performers in the branded pharmaceuticals industry.The 11 branded pharmaceuticals stocks we track reported a mixed Q4. As a group, revenues beat analysts’ consensus estimates by 1.3%.In light of this news, share prices of the companies have held steady. On average, they are relatively unchanged since the latest earnings results.Founded in 1887, Bristol-Myers Squibb  is a global biopharmaceutical company that develops medicines to treat cancer, immune disorders, and cardiovascular conditions.Bristol-Myers Squibb reported revenues of $12.34 billion, up 7.5% year on year. This print exceeded analysts’ expectations by 6.6%. Despite the top-line beat, it was still a mixed quarter for the company with an impressive beat of analysts’ EPS estimates but a significant miss of analysts’ full-year E","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/branded-pharmaceuticals-stocks-q4-review-090318015.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1035773651.USD","TQQQ","LU1941712348.USD","IE00B4R5TH58.HKD","QID","LU0345774391.USD","LU0006306889.USD","LU1023059063.AUD","LU2361044949.HKD","LU1868837300.USD","NVIW.SI","NYSE","NQmain","PSQ","LU1989771016.USD",".IXIC","SQQQ","LU1868836591.USD","USAW.SI","MRK","LU0882574055.USD","LU1585245621.USD","SG9999015341.SGD","QLD","QQQ","MNQmain","LU0203347892.USD","LU2023250843.SGD","USJW.SI","LU0566484027.USD","IE00BJJMRZ35.SGD","LU0208291251.USD","LU1917777945.USD","LU0471298777.SGD","BK4534","CORT","LU0225284248.USD","BK4588","SGXZ57979304.SGD","LU0965509101.SGD","ZTS","SUPN","LU0385154629.USD","IE0002141913.USD","TSYW.SI","IE00B19Z9505.USD","BMY","LU2468319806.SGD","CNS","SG9999014559.SGD"],"gpt_icon":0},{"id":"2516463830","title":"Cassava Sciences Reports 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2516463830","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516463830?lang=en_us&edition=fundamental","pubTime":"2025-03-03 20:30","pubTimestamp":1741005000,"startTime":"0","endTime":"0","summary":"Top-line data for REFOCUS-ALZ, the second Phase 3 study of simufilam in Alzheimer’s disease, expected late first-quarter/early second-quarter 2025License agreement brings potential in a new therapeuti","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/03/3035508/8339/en/Cassava-Sciences-Reports-2024-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4192","BK4588","BK4601","SAVA","BK4007","CNS","BK4547","BK4585","PET","BK4135","ETH"],"gpt_icon":0},{"id":"2516870916","title":"Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-05 in Alzheimer’s Disease Agitation Supporting NDA Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2516870916","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516870916?lang=en_us&edition=fundamental","pubTime":"2025-03-03 20:00","pubTimestamp":1741003200,"startTime":"0","endTime":"0","summary":"Supplemental New Drug Application (sNDA) submission anticipated in 3Q 2025NEW YORK, March  03, 2025  (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/03/3035463/33090/en/Axsome-Therapeutics-Announces-FDA-Pre-NDA-Meeting-Minutes-for-AXS-05-in-Alzheimer-s-Disease-Agitation-Supporting-NDA-Submission.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU0154245673.USD","LU0154245756.USD","CNS","AXS","BK4135","BK4585","BK4107","AXSM","BK4505"],"gpt_icon":0},{"id":"2516687647","title":"Press Release: Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2516687647","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516687647?lang=en_us&edition=fundamental","pubTime":"2025-03-03 20:00","pubTimestamp":1741003200,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development. In his role as CMO, Dr. Sevigny will oversee the development and execution of Rapport's clinical strategy and will be responsible for ensuring the advancement of Rapport's pipeline of precision medicines leveraging receptor associated protein  science. Building on the momentum of Rapport's RAP-219 program, his proven ability to advance clinical programs through late-stage clinical trials and regulatory approval will be instrumental in progressing RAP-219 and the broader pipeline.\"We are thrilled to welcome Jeff to Rapport. His extensive experience leading successful clinical development programs and driving drug development in neuroscience make him the ideal addition to our executive team and leader of our clinical development capability,\" said Abraham N. Ceesay, chief executive officer of Rapport. \"Jeff's proven ability in building e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4023","BK4596","STRK","BK4135","CNS","BK4600","BK4007","RAPP","LENZ","BK4516","BK4595","BK4139","BK4585"],"gpt_icon":1},{"id":"2516217687","title":"Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2516217687","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516217687?lang=en_us&edition=fundamental","pubTime":"2025-03-03 20:00","pubTimestamp":1741003200,"startTime":"0","endTime":"0","summary":"-- LUMRYZ generated $50.4 million in sales in the fourth quarter, up 158% year-over-year, taking the full-year total to $169.1 million, in line with preliminary results published January 8 -- Reiterat","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/03/3035460/0/en/Avadel-Pharmaceuticals-Reiterates-2025-Guidance-as-it-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IH","BK4085","BK4510","BK4135","CNS","BK4563"],"gpt_icon":0},{"id":"2516882156","title":"Cohen & Steers Launches SICAV Short Duration Preferred Income Fund","url":"https://stock-news.laohu8.com/highlight/detail?id=2516882156","media":"CNW Group","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516882156?lang=en_us&edition=fundamental","pubTime":"2025-03-03 17:00","pubTimestamp":1740992400,"startTime":"0","endTime":"0","summary":"LONDON, March 3, 2025 /CNW/ -- Cohen & Steers, Inc.  announced today the launch of the Cohen & Steers SICAV Short Duration Preferred Income Fund. This is the firm's second fund focused on the preferred securities market available to UCITS investors, in addition to the Cohen & Steers SICAV Preferred Income Fund, launched in 2017.Elaine Zaharis-Nikas, Head of Fixed Income and Preferred Securities, said:\"We see significant opportunities in the $1.2 trillion preferred securities market driven by attractive market fundamentals, including an increase in new issuance from institutional, over-the-counter preferreds and contingent capital securities. Recent methodology changes from select rating agencies have also spurred new issuance from non-financial companies, improving the diversification of the preferred securities universe. Overall, we are optimistic about preferreds' return potential and the appeal of short duration strategies.\"","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cohen-steers-launches-sicav-short-090000996.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CNS","BK4135"],"gpt_icon":0},{"id":"2514329163","title":"Praxis Precision Medicines Provides Update on Essential3 and Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2514329163","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514329163?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:00","pubTimestamp":1740747600,"startTime":"0","endTime":"0","summary":"BOSTON, Feb. 28, 2025  -- Praxis Precision Medicines, Inc. , a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system  disorders characterized by neuronal excitation-inhibition imbalance, today provided an update on the interim analysis for Study 1 of the Essential3 program of ulixacaltamide in essential tremor , an update on other therapies in development and a financial update.Results of the Planned Interim Analysis and Update on Topline Read-out for the Essential3 Program:. The EMPOWER observational study, in partnership with the Epilepsy Study Consortium, characterizing seizure burden, is ongoing with over 3,000 patients consented. Early results were shared during the Praxis scientific exhibit at the December 2024 American Epilepsy Society  Annual Meeting, demonstrating significa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/praxis-precision-medicines-provides-essential3-130000962.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4144","LU1093756168.USD","BK4139","PRAX","BK4581","IE0002270589.USD","BK4588","BK4135","IE00B19Z3581.USD","ET","IE00B19Z3B42.SGD","ASO","BK4561","IE00B7SZLL34.SGD","BK4105","BK4585","BK4519","CNS","AES","BK4200","BK4590","MDCO","LU1093756325.SGD","LU0061475181.USD"],"gpt_icon":0},{"id":"2514176354","title":"Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514176354","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514176354?lang=en_us&edition=fundamental","pubTime":"2025-02-28 07:20","pubTimestamp":1740698400,"startTime":"0","endTime":"0","summary":"NEW YORK, Feb. 27, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc.   with information regarding the sources of the distribution to be paid on February 28, 2025 and cumulative distributions paid fiscal year-to-date.In December 2017, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. The managed distribution policy seeks to deliver the Fund's long-term total return potential through regular monthly distributions declared at a fixed rate per common share. The policy gives the Fund greater flexibility to realize long-term capital gains throughout the year and to distribute those gains on a regular monthly basis to shareholders. The Board of Directors of the Fund may amend, terminate or suspend the managed distribution policy at any time, which could have an adverse effect on the market price of the Fund's shares.The following table s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/cohen-steers-reit-preferred-income-232000377.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cohen-steers-reit-preferred-income-232000377.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RNP","REIT","NAV","BK4135","CNS"],"gpt_icon":0},{"id":"2514358922","title":"Alumis Presents Additional Phase 1 Data at ACTRIMS Forum 2025 Supporting Potential of A-005 as First-in-Class CNS Penetrant TYK2 Inhibitor for Treatment of Neuroinflammatory and Neurodegenerative Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2514358922","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514358922?lang=en_us&edition=fundamental","pubTime":"2025-02-28 05:15","pubTimestamp":1740690900,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Feb. 27, 2025  -- Alumis Inc.  , a clinical stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with immune-mediated diseases, today announced the Company will give two data presentations on A-005, a potent, selective, central nervous system  penetrant tyrosine kinase 2  inhibitor, on Friday, February 28, 2025, at the 10th Annual Americas Committee for Treatment and Research in Multiple Sclerosis  Forum 2025.“These data demonstrate that A-005 potently inhibits TYK2-specific signaling in immune cells and CNS resident cells, targeting pro-inflammatory cytokine pathways implicated in the pathology of neuroinflammatory diseases,” said Jrn Drappa, M.D., Alumis’ Chief Medical Officer. “As the first reported allosteric TYK2 inhibitor with demonstrated ability to cross the blood-brain barrier, A-005 represents a novel approach to potentially treating a bro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alumis-presents-additional-phase-1-211500176.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALMS","BK4181","BK4007","LU1169590202.USD","LU1169589451.USD","PK","FET","BK4023","BK4179","BK4218","BK4135","PD","CNS"],"gpt_icon":0},{"id":"2514733096","title":"Virpax Reports Positive Results in Human Study for its Molecular Envelope Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2514733096","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514733096?lang=en_us&edition=fundamental","pubTime":"2025-02-28 05:01","pubTimestamp":1740690060,"startTime":"0","endTime":"0","summary":"BERWYN, Pa., February 27, 2025----Virpax Pharmaceuticals, Inc.  , a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system  disorders and anti-viral barrier indications, would like to congratulate Nanomerics on completing a human study using the Molecular Envelope Technology  and showing no moderate to severe adverse events. Virpax uses MET in its Envelta  and NobrXiol.In addition, Virpax uses MET with NobrXiol. NobrXiol is being developed for delivery of cannabidiol in the management of epilepsy in children and adults. NobrXiol utilizes the MET as its delivery system to cross the blood brain barrier, propelling the cannabidiol nanoparticles through the nose to the brain via the olfactory nerve. The drug has received pre-Investigational New Drug  application guidance from the U.S. Food and Drug Administration ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/virpax-reports-positive-results-human-210100424.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4162","BK4007","CBD","LU1989772923.USD","LU1291159041.SGD","LU1989771016.USD","IE00B29SXL02.USD","VRPX","DOD","CNS","MET","LU1989772840.SGD","LU1496350502.SGD","IE00B29SXK94.USD","BK4588","BK4135","BK4585","BK4113"],"gpt_icon":0},{"id":"2514099448","title":"TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2514099448","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514099448?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:30","pubTimestamp":1740659400,"startTime":"0","endTime":"0","summary":"NEW YORK, Feb.  27, 2025  (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data from the ULTIMATE I & II Phase 3 trials and the ENHANCE Phase 3b trial eval","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/27/3033752/8790/en/TG-Therapeutics-Announces-Presentation-of-Data-for-BRIUMVI-in-Multiple-Sclerosis-at-the-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis-Annual-Forum.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EC","BK4135","LU2133065610.SGD","BK4139","LU1989772923.USD","LU0098860793.USD","LU2357305700.SGD","LU0006306889.USD","LU0106831901.USD","LU0225283273.USD","LU0795875086.SGD","BK4504","LU2271345857.HKD","LU0912757837.SGD","IE00BKVL7J92.USD","LU1720051108.HKD","LU0971096721.USD","BK4581","BK4516","TGTX","BK4585","LU0795875169.SGD","LU2028103732.USD","LU0158827948.USD","BK4153","LU1720051017.SGD","LU1548497426.USD","LU1732800096.USD","BK4179","BK4201","LU2089284900.SGD","LU0106261372.USD","LU0158827781.USD","LU1668664300.SGD","BK4534","BK4588","FET","BK4090","LU2023251221.USD","LU2089283258.USD","LU2111349929.HKD","PML","TG","LU1989772840.SGD","LU1162221912.USD","BK4127","CNS","LU1732799900.SGD","LU0267386448.USD","LU1074936037.SGD"],"gpt_icon":0},{"id":"2514805455","title":"Cassava Sciences Licenses Simufilam Method of Treatment Patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2514805455","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514805455?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:00","pubTimestamp":1740657600,"startTime":"0","endTime":"0","summary":"Cassava enters into a license agreement with Yale University granting intellectual property rights, including rights to an issued US method of treatment patent for potential treatment with simufilam of seizures related to rare neurodevelopmental disorders. The licensed patent is based on research led by Yale University and published in Science Translational Medicine showing that treatment with simufilam appeared to meaningfully reduce seizure frequency in an animal model. Cassava will prioritize initial development efforts on tuberous sclerosis complex -related seizures. The intellectual property that Cassava has licensed is based on the promising research and development work of Angélique Bordey, PhD, Professor of Neurosurgery and Vice Chair of Research, Neurosurgery at Yale, and her collaborators. In a paper published in Science Translational Medicine2 in 2020, the researchers showed that treatment with simufilam  appeared to meaningfully reduce TSC-related seizure frequency in an an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cassava-sciences-licenses-simufilam-method-120000627.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CNS","BK4135","BK4547","SAVAW","BK4585","BK4007","SAVA","BK4588"],"gpt_icon":0},{"id":"2514877816","title":"Cohen & Steers, Inc. (NYSE:CNS) Stock Goes Ex-Dividend In Just Three Days","url":"https://stock-news.laohu8.com/highlight/detail?id=2514877816","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514877816?lang=en_us&edition=fundamental","pubTime":"2025-02-27 18:39","pubTimestamp":1740652767,"startTime":"0","endTime":"0","summary":"Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Cohen & Steers, Inc.  is about to trade ex-dividend in the next 3 days. The ex-dividend date is usually set to be one business day before the record date, which is the cut-off date on which you must be present on the company's books as a shareholder in order to receive the dividend. The ex-dividend date is of consequence because whenever a stock is bought or sold, the trade takes at least one business day to settle. Accordingly, Cohen & Steers investors that purchase the stock on or after the 3rd of March will not receive the dividend, which will be paid on the 13th of March.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cohen-steers-inc-nyse-cns-103927460.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NYSE","CNS","BK4135"],"gpt_icon":0},{"id":"2514888869","title":"Silo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2514888869","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514888869?lang=en_us&edition=fundamental","pubTime":"2025-02-27 02:30","pubTimestamp":1740594600,"startTime":"0","endTime":"0","summary":"SARASOTA, FL, Feb.  26, 2025  (GLOBE NEWSWIRE) --  Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug de","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/26/3033230/0/en/Silo-Pharma-Granted-U-S-Patent-for-Novel-Intranasal-Post-Traumatic-Stress-Disorder-Treatment.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["POST","BK4212","BK4135","CNS"],"gpt_icon":0},{"id":"2514855342","title":"CNS Pharmaceuticals reports cash position of $14M as of February 26","url":"https://stock-news.laohu8.com/highlight/detail?id=2514855342","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514855342?lang=en_us&edition=fundamental","pubTime":"2025-02-26 22:20","pubTimestamp":1740579650,"startTime":"0","endTime":"0","summary":"CNS Pharmaceuticals (CNSP) provided an update on its current cash position and discussed the completion of its recent initiative to maintain its li...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cns-pharmaceuticals-reports-cash-position-of-14m-as-of-february-26?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cns-pharmaceuticals-reports-cash-position-of-14m-as-of-february-26?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4135","CNS","CNSP"],"gpt_icon":0},{"id":"2514530508","title":"CNS Pharmaceuticals Provides Update on Current Cash Position and NASDAQ Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2514530508","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514530508?lang=en_us&edition=fundamental","pubTime":"2025-02-26 22:05","pubTimestamp":1740578700,"startTime":"0","endTime":"0","summary":"Cash on hand provides over one year of runway to fund expected operations. HOUSTON, TX / ACCESS Newswire / February 26, 2025 / CNS Pharmaceuticals, Inc.  , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today provided an update on its current cash position and discussed the completion of its recent initiative to maintain its listing on the NASDAQ Capital Market .The Company's lead drug candidate, Berubicin, is the first anthracycline to appear to cross the blood-brain barrier. Berubicin is the subject of the Company's late-stage, fully-enrolled, global clinical trial for the treatment of glioblastoma multiforme , an aggressive and currently incurable form of brain cancer. The Company expects to release primary analysis data on Berubicin's performance in this designed-to-be pivo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cns-pharmaceuticals-provides-current-cash-140500098.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SQQQ","QLD","CNS","NVIW.SI","LU2095319765.USD","USJW.SI","MNQmain","IE00B3QW5Z07.USD","NQmain","BK4588","BK4007","TQQQ","BK4112","LU2210149790.SGD","BK4585","IE00B64PRP62.GBP","LU2210150020.SGD","TSYW.SI","NDAQ","QID","IE00BKPKM429.USD","IE00BGHQF748.EUR","USAW.SI","PSQ","CNSP","BK4135",".IXIC"],"gpt_icon":1},{"id":"2514832411","title":"Press Release: Taysha Gene Therapies Reports Full-Year 2024 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2514832411","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514832411?lang=en_us&edition=fundamental","pubTime":"2025-02-26 21:00","pubTimestamp":1740574800,"startTime":"0","endTime":"0","summary":"High dose and low dose of TSHA-102 continue to be generally well tolerated with no treatment-related SAEs or DLTs in all pediatric, adolescent and adult patients treated  across both REVEAL trials as of February 2025 data cutoff. Completed dosing of the 10 patients in Part A of both REVEAL trials; maturing dataset continues to support advancement toward pivotal Part B trial. Productive ongoing discussions with the FDA to solidify regulatory pathway for TSHA-102; update on pivotal trial design expected in H1 2025. Clinical data from cohort two  and cohort one  of both REVEAL trials expected in H1 2025. Conference call and live webcast today at 8:30 AM Eastern Time. DALLAS, Feb. 26, 2025  -- Taysha Gene Therapies, Inc.  , a clinical-stage biotechnology company focused on advancing adeno-associated virus -based gene therapies for severe monogenic diseases of the central nervous system , today reported financial results for the full year ended December 31, 2024, and provided a corporate up","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","CNS","TSHA","BK4139"],"gpt_icon":0},{"id":"2514619834","title":"Plus Therapeutics Advances Lead Drug Rhenium (186Re) Obisbemeda for Patients with Leptomeningeal Metastases","url":"https://stock-news.laohu8.com/highlight/detail?id=2514619834","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514619834?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:30","pubTimestamp":1740573000,"startTime":"0","endTime":"0","summary":"ReSPECT- LM Phase 1 single dose is now complete, and the recommended Phase 2 dose (RP2D) for single administration therapy has been determinedAUSTIN, Texas, Feb.  26, 2025  (GLOBE NEWSWIRE) -- Plus Th","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/26/3032822/0/en/Plus-Therapeutics-Advances-Lead-Drug-Rhenium-186Re-Obisbemeda-for-Patients-with-Leptomeningeal-Metastases.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","CNS","BK4135","CSF","BK4139"],"gpt_icon":0},{"id":"2514838441","title":"Cohen & Steers (NYSE:CNS) Is Paying Out A Larger Dividend Than Last Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2514838441","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514838441?lang=en_us&edition=fundamental","pubTime":"2025-02-26 18:38","pubTimestamp":1740566322,"startTime":"0","endTime":"0","summary":"Cohen & Steers, Inc.  will increase its dividend from last year's comparable payment on the 13th of March to $0.62. This will take the dividend yield to an attractive 2.8%, providing a nice boost to shareholder returns.Cohen & Steers' Future Dividend Projections Appear Well Covered By Earnings. Impressive dividend yields are good, but this doesn't matter much if the payments can't be sustained. Prior to this announcement, Cohen & Steers' dividend was making up a very large proportion of earnings and perhaps more concerning was that it was 149% of cash flows. This is certainly a risk factor, as reduced cash flows could force the company to pay a lower dividend.Companies possessing a stable dividend policy will likely enjoy greater investor interest than those suffering from a more inconsistent approach. Meanwhile, despite the importance of dividend payments, they are not the only factors our readers should know when assessing a company. Just as an example, we've come across 3 warning si","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cohen-steers-nyse-cns-paying-103842714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NYSE","CNS","BK4135"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CNS\",params:#limit:5,,,undefined,":[{"date":"2025-05-12","symbol":"CNS","amount":0.62,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-12","defaultRemindTime":1747056600000,"name":"科恩-斯蒂尔斯金融","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-22","payableDate":"2025-05-12","currency":"USD","dateTimestamp":1747022400000,"payDate":"2025-05-22"},{"date":"2025-04-16","symbol":"CNS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":null,"defaultRemindTime":1744833600000,"name":null,"time":"Post Market","dateTimestamp":1744776000000,"actualEps":null},{"date":"2025-03-03","symbol":"CNS","amount":0.62,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-03","defaultRemindTime":1741012200000,"name":"科恩-斯蒂尔斯金融","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-13","payableDate":"2025-03-03","currency":"USD","dateTimestamp":1740978000000,"payDate":"2025-03-13"},{"market":"US","date":"2025-01-22","symbol":"CNS","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1737522000000,"reportTimeType":"post","actualEps":0.78},{"date":"2024-11-18","symbol":"CNS","amount":0.59,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-18","defaultRemindTime":1731940200000,"name":"科恩-斯蒂尔斯金融","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-02","payableDate":"2024-11-18","currency":"USD","dateTimestamp":1731906000000,"payDate":"2024-12-02"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CNS\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-29","recordDate":"2015-06-02","paymentDate":"2015-06-25","value":0.25,"currency":"USD"},{"executeDate":"2015-09-01","recordDate":"2015-09-03","paymentDate":"2015-09-24","value":0.25,"currency":"USD"},{"executeDate":"2015-11-23","recordDate":"2015-11-25","paymentDate":"2015-12-16","value":0.75,"currency":"USD"},{"executeDate":"2016-03-07","recordDate":"2016-03-09","paymentDate":"2016-03-23","value":0.26,"currency":"USD"},{"executeDate":"2016-05-31","recordDate":"2016-06-02","paymentDate":"2016-06-23","value":0.26,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CNS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1729137600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CNS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CNS","date":"2025-05-05","current":25.470263,"percent":0.47117,"low":12.87852,"twenty":18.128761,"median":26.303934,"eighty":33.522419,"high":43.702499,"avg":26.234392,"sd":7.579449,"marketCap":3999824658},"quantilePoints":[{"date":"2020-05-08","current":24.886471,"twenty":17.91219,"median":21.888209,"eighty":25.763067,"marketCap":3052325677},{"date":"2020-05-15","current":23.172849,"twenty":17.91219,"median":21.888209,"eighty":25.763067,"marketCap":2842149887},{"date":"2020-05-22","current":24.878682,"twenty":17.91219,"median":21.888209,"eighty":25.763067,"marketCap":3051370333},{"date":"2020-05-29","current":24.75016,"twenty":17.91219,"median":21.888209,"eighty":25.782303,"marketCap":3035607148},{"date":"2020-06-05","current":28.695386,"twenty":17.91219,"median":21.888209,"eighty":25.792568,"marketCap":3519489138},{"date":"2020-06-12","current":26.802613,"twenty":17.91219,"median":21.888209,"eighty":25.860348,"marketCap":3287340424},{"date":"2020-06-19","current":27.643845,"twenty":17.91219,"median":21.929604,"eighty":25.901982,"marketCap":3390517630},{"date":"2020-06-26","current":25.143514,"twenty":17.91219,"median":21.929604,"eighty":25.953213,"marketCap":3083852046},{"date":"2020-07-02","current":26.319683,"twenty":17.91219,"median":21.967124,"eighty":25.986175,"marketCap":3228109065},{"date":"2020-07-10","current":26.152215,"twenty":17.91219,"median":22.016567,"eighty":25.992492,"marketCap":3207569158},{"date":"2020-07-17","current":26.362523,"twenty":17.91219,"median":22.08441,"eighty":26.071486,"marketCap":3233363460},{"date":"2020-07-24","current":25.339106,"twenty":17.91219,"median":22.145224,"eighty":26.111636,"marketCap":3036562493},{"date":"2020-07-31","current":23.987847,"twenty":17.91219,"median":22.179183,"eighty":26.111636,"marketCap":2874631600},{"date":"2020-08-07","current":24.132484,"twenty":17.91219,"median":22.253822,"eighty":26.111636,"marketCap":2891964508},{"date":"2020-08-14","current":24.666724,"twenty":17.935145,"median":22.29366,"eighty":26.111636,"marketCap":2955986191},{"date":"2020-08-21","current":24.654763,"twenty":17.935145,"median":22.345044,"eighty":26.111636,"marketCap":2954552870},{"date":"2020-08-28","current":24.499276,"twenty":17.958411,"median":22.424008,"eighty":26.111636,"marketCap":2935919693},{"date":"2020-09-04","current":23.969023,"twenty":18.000138,"median":22.496172,"eighty":26.111636,"marketCap":2872375785},{"date":"2020-09-11","current":23.263348,"twenty":18.099298,"median":22.501958,"eighty":26.111636,"marketCap":2787809831},{"date":"2020-09-18","current":22.832767,"twenty":18.192403,"median":22.546509,"eighty":26.111636,"marketCap":2736210266},{"date":"2020-09-25","current":22.155,"twenty":18.28108,"median":22.546509,"eighty":26.111636,"marketCap":2654988728},{"date":"2020-10-02","current":22.705187,"twenty":18.403976,"median":22.566583,"eighty":26.111636,"marketCap":2720921506},{"date":"2020-10-09","current":23.602231,"twenty":18.52773,"median":22.594828,"eighty":26.111636,"marketCap":2828420600},{"date":"2020-10-16","current":23.598244,"twenty":18.562573,"median":22.670837,"eighty":26.111636,"marketCap":2827942826},{"date":"2020-10-23","current":23.437391,"twenty":18.624451,"median":22.7205,"eighty":26.111636,"marketCap":2759143406},{"date":"2020-10-30","current":22.852978,"twenty":18.788661,"median":22.762059,"eighty":26.111636,"marketCap":2690343986},{"date":"2020-11-06","current":23.997588,"twenty":18.837817,"median":22.78812,"eighty":26.111636,"marketCap":2825092062},{"date":"2020-11-13","current":25.820138,"twenty":18.884452,"median":22.835905,"eighty":26.122473,"marketCap":3039649967},{"date":"2020-11-20","current":28.109489,"twenty":18.914144,"median":22.857139,"eighty":26.15386,"marketCap":3309161456},{"date":"2020-11-27","current":29.432766,"twenty":18.924936,"median":22.889551,"eighty":26.180357,"marketCap":3464942919},{"date":"2020-12-04","current":30.557145,"twenty":18.972497,"median":22.931471,"eighty":26.234833,"marketCap":3597309378},{"date":"2020-12-11","current":30.5815,"twenty":19.026142,"median":22.993772,"eighty":26.256821,"marketCap":3600176521},{"date":"2020-12-18","current":30.191823,"twenty":19.058337,"median":23.028301,"eighty":26.31233,"marketCap":3554302225},{"date":"2020-12-24","current":29.794029,"twenty":19.093721,"median":23.060018,"eighty":26.337042,"marketCap":3507472215},{"date":"2020-12-31","current":30.15935,"twenty":19.103205,"median":23.125625,"eighty":26.362312,"marketCap":3550479367},{"date":"2021-01-08","current":29.091799,"twenty":19.162181,"median":23.160033,"eighty":26.401457,"marketCap":3424802910},{"date":"2021-01-15","current":29.887389,"twenty":19.202231,"median":23.200606,"eighty":26.441488,"marketCap":3518462931},{"date":"2021-01-22","current":29.74126,"twenty":19.221971,"median":23.235659,"eighty":26.487931,"marketCap":3501260070},{"date":"2021-01-29","current":40.869698,"twenty":19.278958,"median":23.263348,"eighty":26.526288,"marketCap":3129964987},{"date":"2021-02-05","current":42.298578,"twenty":19.312251,"median":23.304616,"eighty":26.539566,"marketCap":3239394297},{"date":"2021-02-12","current":43.072294,"twenty":19.369502,"median":23.346381,"eighty":26.568376,"marketCap":3298648596},{"date":"2021-02-19","current":41.312714,"twenty":19.404944,"median":23.412011,"eighty":26.604536,"marketCap":3163892852},{"date":"2021-02-26","current":40.543706,"twenty":19.462875,"median":23.44404,"eighty":26.627953,"marketCap":3104999179},{"date":"2021-03-05","current":41.494638,"twenty":19.519205,"median":23.521823,"eighty":26.663067,"marketCap":3177825348},{"date":"2021-03-12","current":42.773043,"twenty":19.606366,"median":23.562376,"eighty":26.674223,"marketCap":3275730727},{"date":"2021-03-19","current":41.356092,"twenty":19.606366,"median":23.598948,"eighty":26.704024,"marketCap":3167214913},{"date":"2021-03-26","current":40.990833,"twenty":19.607142,"median":23.626615,"eighty":26.73796,"marketCap":3139241947},{"date":"2021-04-01","current":42.307023,"twenty":19.607142,"median":23.674531,"eighty":26.795994,"marketCap":3240041082},{"date":"2021-04-09","current":41.878789,"twenty":19.606366,"median":23.704202,"eighty":26.872012,"marketCap":3207245191},{"date":"2021-04-16","current":42.502248,"twenty":19.606366,"median":23.710206,"eighty":26.913332,"marketCap":3254992149},{"date":"2021-04-23","current":31.693219,"twenty":19.606366,"median":23.710206,"eighty":27.029751,"marketCap":3323477686},{"date":"2021-04-30","current":31.283888,"twenty":19.606366,"median":23.755094,"eighty":27.056161,"marketCap":3280553653},{"date":"2021-05-07","current":32.560979,"twenty":19.606366,"median":23.782134,"eighty":27.213028,"marketCap":3414474551},{"date":"2021-05-14","current":33.61905,"twenty":19.606366,"median":23.8007,"eighty":27.25402,"marketCap":3525428090},{"date":"2021-05-21","current":33.200422,"twenty":19.606366,"median":23.839623,"eighty":27.262589,"marketCap":3481529081},{"date":"2021-05-28","current":33.642052,"twenty":19.606366,"median":23.883463,"eighty":27.340067,"marketCap":3527840123},{"date":"2021-06-04","current":34.226291,"twenty":19.606366,"median":23.921975,"eighty":27.431277,"marketCap":3589105773},{"date":"2021-06-11","current":34.424104,"twenty":19.606366,"median":23.95944,"eighty":27.60508,"marketCap":3609849261},{"date":"2021-06-18","current":35.633985,"twenty":19.606366,"median":23.983072,"eighty":27.65774,"marketCap":3736722220},{"date":"2021-06-25","current":37.754727,"twenty":19.606366,"median":24.001439,"eighty":27.731371,"marketCap":3959111704},{"date":"2021-07-02","current":37.317698,"twenty":19.606366,"median":24.019996,"eighty":27.803594,"marketCap":3913283069},{"date":"2021-07-09","current":36.871468,"twenty":19.606366,"median":24.065621,"eighty":27.878924,"marketCap":3866489620},{"date":"2021-07-16","current":36.443639,"twenty":19.606366,"median":24.065621,"eighty":27.954254,"marketCap":3821625798},{"date":"2021-07-23","current":32.23161,"twenty":19.606366,"median":24.065621,"eighty":28.3446,"marketCap":3962006144},{"date":"2021-07-30","current":32.655452,"twenty":19.606366,"median":24.065621,"eighty":28.597983,"marketCap":4014106067},{"date":"2021-08-06","current":34.262979,"twenty":19.606366,"median":24.065621,"eighty":28.779046,"marketCap":4211708107},{"date":"2021-08-13","current":34.608395,"twenty":19.606366,"median":24.065621,"eighty":28.919847,"marketCap":4254167761},{"date":"2021-08-20","current":34.376809,"twenty":19.606366,"median":24.065621,"eighty":29.018684,"marketCap":4225700493},{"date":"2021-08-27","current":34.690824,"twenty":19.606366,"median":24.065621,"eighty":29.125292,"marketCap":4264300178},{"date":"2021-09-03","current":34.518116,"twenty":19.606366,"median":24.065621,"eighty":29.237927,"marketCap":4243070351},{"date":"2021-09-10","current":34.015692,"twenty":19.606366,"median":24.065621,"eighty":29.325721,"marketCap":4181310855},{"date":"2021-09-17","current":34.235502,"twenty":19.606366,"median":24.065621,"eighty":29.428707,"marketCap":4208330635},{"date":"2021-09-24","current":33.650649,"twenty":19.606366,"median":24.065621,"eighty":29.513948,"marketCap":4136438722},{"date":"2021-10-01","current":33.485791,"twenty":19.606366,"median":24.065621,"eighty":29.715133,"marketCap":4116173887},{"date":"2021-10-08","current":33.897936,"twenty":19.607142,"median":24.072911,"eighty":29.833679,"marketCap":4166835974},{"date":"2021-10-15","current":34.282604,"twenty":19.607142,"median":24.072911,"eighty":29.886999,"marketCap":4214120588},{"date":"2021-10-22","current":31.39397,"twenty":19.607142,"median":24.120524,"eighty":29.97263,"marketCap":4473703468},{"date":"2021-10-29","current":32.128708,"twenty":19.607919,"median":24.159112,"eighty":30.0979,"marketCap":4578405113},{"date":"2021-11-05","current":34.01649,"twenty":19.607919,"median":24.231662,"eighty":30.206436,"marketCap":4847417859},{"date":"2021-11-12","current":33.779441,"twenty":19.607919,"median":24.272267,"eighty":30.2663,"marketCap":4813637944},{"date":"2021-11-19","current":33.335822,"twenty":19.607919,"median":24.34227,"eighty":30.314228,"marketCap":4750421245},{"date":"2021-11-26","current":31.585048,"twenty":19.607919,"median":24.388858,"eighty":30.347179,"marketCap":4500932441},{"date":"2021-12-03","current":30.152596,"twenty":19.607919,"median":24.435486,"eighty":30.418709,"marketCap":4296805238},{"date":"2021-12-10","current":30.687649,"twenty":19.607919,"median":24.495428,"eighty":30.555834,"marketCap":4373051333},{"date":"2021-12-17","current":30.917925,"twenty":19.607919,"median":24.535811,"eighty":30.628753,"marketCap":4405866108},{"date":"2021-12-23","current":30.464146,"twenty":19.607919,"median":24.549254,"eighty":30.66128,"marketCap":4341201699},{"date":"2021-12-31","current":31.32768,"twenty":19.607919,"median":24.669496,"eighty":30.712708,"marketCap":4464257105},{"date":"2022-01-07","current":30.782468,"twenty":19.609472,"median":24.728839,"eighty":30.771039,"marketCap":4386563299},{"date":"2022-01-14","current":29.597225,"twenty":19.609472,"median":24.776362,"eighty":30.771039,"marketCap":4217663722},{"date":"2022-01-21","current":28.411981,"twenty":19.609472,"median":24.864401,"eighty":30.771039,"marketCap":4048764145},{"date":"2022-01-28","current":18.641168,"twenty":19.590769,"median":24.917596,"eighty":30.771039,"marketCap":3940668416},{"date":"2022-02-04","current":18.285055,"twenty":19.499836,"median":24.917596,"eighty":30.771039,"marketCap":3865387462},{"date":"2022-02-11","current":18.433435,"twenty":19.415099,"median":24.917596,"eighty":30.771039,"marketCap":3896754526},{"date":"2022-02-18","current":18.221137,"twenty":19.383827,"median":24.917596,"eighty":30.771039,"marketCap":3851875496},{"date":"2022-02-25","current":18.59767,"twenty":19.32955,"median":24.882576,"eighty":30.771039,"marketCap":3931473126},{"date":"2022-03-04","current":17.962167,"twenty":19.282693,"median":24.776362,"eighty":30.771039,"marketCap":3797130353},{"date":"2022-03-11","current":17.870066,"twenty":19.226995,"median":24.690202,"eighty":30.771039,"marketCap":3777660385},{"date":"2022-03-18","current":19.069692,"twenty":19.199701,"median":24.590174,"eighty":30.771039,"marketCap":4031256708},{"date":"2022-03-25","current":19.266364,"twenty":19.165812,"median":24.531824,"eighty":30.771039,"marketCap":4072832201},{"date":"2022-04-01","current":20.194336,"twenty":19.165812,"median":24.414953,"eighty":30.771039,"marketCap":4269001841},{"date":"2022-04-08","current":19.798278,"twenty":19.165812,"median":24.34446,"eighty":30.771039,"marketCap":4185276833},{"date":"2022-04-14","current":19.006163,"twenty":19.164835,"median":24.272267,"eighty":30.771039,"marketCap":4017826818},{"date":"2022-04-22","current":19.515002,"twenty":19.160428,"median":24.159112,"eighty":30.771039,"marketCap":3992027833},{"date":"2022-04-29","current":18.48702,"twenty":19.120759,"median":24.109263,"eighty":30.771039,"marketCap":3781741767},{"date":"2022-05-06","current":18.140576,"twenty":19.097352,"median":24.008501,"eighty":30.771039,"marketCap":3710872529},{"date":"2022-05-13","current":17.343267,"twenty":19.068709,"median":23.966477,"eighty":30.771039,"marketCap":3547773304},{"date":"2022-05-20","current":17.248065,"twenty":19.045263,"median":23.843035,"eighty":30.771039,"marketCap":3528298769},{"date":"2022-05-27","current":18.354779,"twenty":19.014348,"median":23.76195,"eighty":30.771039,"marketCap":3754690232},{"date":"2022-06-03","current":17.897813,"twenty":18.977944,"median":23.679147,"eighty":30.771039,"marketCap":3661212467},{"date":"2022-06-10","current":16.634018,"twenty":18.947577,"median":23.585518,"eighty":30.771039,"marketCap":3402688023},{"date":"2022-06-17","current":15.608226,"twenty":18.914815,"median":23.455654,"eighty":30.689004,"marketCap":3192849914},{"date":"2022-06-24","current":16.260354,"twenty":18.900025,"median":23.315177,"eighty":30.690358,"marketCap":3326250475},{"date":"2022-07-01","current":15.477324,"twenty":18.870215,"median":23.246645,"eighty":30.690358,"marketCap":3166072430},{"date":"2022-07-08","current":15.736747,"twenty":18.832714,"median":23.109571,"eighty":30.614098,"marketCap":3219140536},{"date":"2022-07-15","current":16.162773,"twenty":18.79571,"median":22.956359,"eighty":30.520819,"marketCap":3306289077},{"date":"2022-07-22","current":16.110583,"twenty":18.706811,"median":22.835905,"eighty":30.406577,"marketCap":3382239761},{"date":"2022-07-29","current":17.089231,"twenty":18.655675,"median":22.723109,"eighty":30.285785,"marketCap":3587696099},{"date":"2022-08-05","current":17.336827,"twenty":18.60341,"median":22.666493,"eighty":30.247635,"marketCap":3639676038},{"date":"2022-08-12","current":18.014155,"twenty":18.576102,"median":22.585581,"eighty":30.247635,"marketCap":3781873710},{"date":"2022-08-19","current":17.726522,"twenty":18.553033,"median":22.523144,"eighty":30.247635,"marketCap":3721488397},{"date":"2022-08-26","current":17.097906,"twenty":18.483674,"median":22.467927,"eighty":30.247635,"marketCap":3589517270},{"date":"2022-09-02","current":16.432175,"twenty":18.396609,"median":22.353732,"eighty":30.247635,"marketCap":3449754489},{"date":"2022-09-09","current":17.31595,"twenty":18.356371,"median":22.298527,"eighty":30.247635,"marketCap":3635293233},{"date":"2022-09-16","current":16.842748,"twenty":18.283229,"median":22.249478,"eighty":30.247635,"marketCap":3535949654},{"date":"2022-09-23","current":15.91722,"twenty":18.21193,"median":22.179183,"eighty":30.247635,"marketCap":3341645300},{"date":"2022-09-30","current":14.527769,"twenty":18.176655,"median":22.123505,"eighty":30.247635,"marketCap":3049945280},{"date":"2022-10-07","current":14.019773,"twenty":18.104175,"median":22.045314,"eighty":30.247635,"marketCap":2943297026},{"date":"2022-10-14","current":12.87852,"twenty":18.032153,"median":21.992474,"eighty":30.247635,"marketCap":2703703688},{"date":"2022-10-21","current":13.875906,"twenty":17.988291,"median":21.929604,"eighty":30.247635,"marketCap":2817169639},{"date":"2022-10-28","current":14.518731,"twenty":17.957216,"median":21.836807,"eighty":30.247635,"marketCap":2947679831},{"date":"2022-11-04","current":14.228587,"twenty":17.927938,"median":21.723866,"eighty":30.232415,"marketCap":2888773025},{"date":"2022-11-11","current":16.001462,"twenty":17.901888,"median":21.670268,"eighty":30.232415,"marketCap":3248712878},{"date":"2022-11-18","current":15.814339,"twenty":17.857353,"median":21.62555,"eighty":30.232415,"marketCap":3210721932},{"date":"2022-11-25","current":15.672797,"twenty":17.824307,"median":21.559545,"eighty":30.232415,"marketCap":3181985192},{"date":"2022-12-02","current":16.212576,"twenty":17.737907,"median":21.517024,"eighty":30.232415,"marketCap":3291574457},{"date":"2022-12-09","current":16.03025,"twenty":17.634502,"median":21.398073,"eighty":30.232415,"marketCap":3254557638},{"date":"2022-12-16","current":15.432895,"twenty":17.536399,"median":21.363322,"eighty":30.232415,"marketCap":3133278852},{"date":"2022-12-23","current":15.157007,"twenty":17.453772,"median":21.291372,"eighty":30.232415,"marketCap":3077266561},{"date":"2022-12-30","current":15.488072,"twenty":17.435795,"median":21.271518,"eighty":30.232415,"marketCap":3144481310},{"date":"2023-01-06","current":16.500458,"twenty":17.354712,"median":21.218395,"eighty":30.232415,"marketCap":3350022065},{"date":"2023-01-13","current":17.735954,"twenty":17.299707,"median":21.152857,"eighty":30.232415,"marketCap":3600859716},{"date":"2023-01-20","current":17.532037,"twenty":17.272433,"median":21.104444,"eighty":30.232415,"marketCap":3559459327},{"date":"2023-01-27","current":20.240915,"twenty":17.272433,"median":21.102629,"eighty":30.232415,"marketCap":3462046647},{"date":"2023-02-03","current":21.659032,"twenty":17.272433,"median":21.116232,"eighty":30.232415,"marketCap":3704604220},{"date":"2023-02-10","current":21.055336,"twenty":17.272433,"median":21.15785,"eighty":30.232415,"marketCap":3601346779},{"date":"2023-02-17","current":21.129374,"twenty":17.272433,"median":21.159455,"eighty":30.232415,"marketCap":3614010428},{"date":"2023-02-24","current":20.698656,"twenty":17.272433,"median":21.159455,"eighty":30.232415,"marketCap":3540339494},{"date":"2023-03-03","current":20.580952,"twenty":17.272433,"median":21.159455,"eighty":30.232415,"marketCap":3520207189},{"date":"2023-03-10","current":18.634532,"twenty":17.272433,"median":21.15785,"eighty":30.232415,"marketCap":3187287608},{"date":"2023-03-17","current":18.169458,"twenty":17.272433,"median":21.116232,"eighty":30.232415,"marketCap":3107740452},{"date":"2023-03-24","current":17.469835,"twenty":17.272433,"median":21.115136,"eighty":30.232415,"marketCap":2988075455},{"date":"2023-03-31","current":18.362705,"twenty":17.273887,"median":21.10979,"eighty":30.224296,"marketCap":3140793856},{"date":"2023-04-06","current":17.72248,"twenty":17.272433,"median":21.115136,"eighty":30.232415,"marketCap":3031288379},{"date":"2023-04-14","current":17.659318,"twenty":17.270978,"median":21.115684,"eighty":30.240533,"marketCap":3020485148},{"date":"2023-04-20","current":18.415569,"twenty":17.270978,"median":21.115684,"eighty":30.240533,"marketCap":3026377819},{"date":"2023-04-28","current":17.701417,"twenty":17.269524,"median":21.116232,"eighty":30.248652,"marketCap":2909015447},{"date":"2023-05-05","current":16.207374,"twenty":17.258712,"median":21.116232,"eighty":30.248652,"marketCap":2663487472},{"date":"2023-05-12","current":16.342745,"twenty":17.216458,"median":21.122803,"eighty":30.25677,"marketCap":2685734018},{"date":"2023-05-19","current":16.937516,"twenty":17.1325,"median":21.129374,"eighty":30.263026,"marketCap":2783477447},{"date":"2023-05-26","current":16.037888,"twenty":17.093405,"median":21.143612,"eighty":30.269283,"marketCap":2635634371},{"date":"2023-06-01","current":16.262047,"twenty":17.038241,"median":21.15785,"eighty":30.275539,"marketCap":2672472347},{"date":"2023-06-09","current":18.405015,"twenty":17.00976,"median":21.159455,"eighty":30.288052,"marketCap":3024643395},{"date":"2023-06-16","current":18.36915,"twenty":17.00976,"median":21.159455,"eighty":30.288052,"marketCap":3018749319},{"date":"2023-06-23","current":17.173631,"twenty":16.999409,"median":21.167314,"eighty":30.322625,"marketCap":2822280115},{"date":"2023-06-30","current":17.421701,"twenty":16.956799,"median":21.19089,"eighty":30.357198,"marketCap":2863047475},{"date":"2023-07-07","current":17.176619,"twenty":16.955322,"median":21.194819,"eighty":30.374484,"marketCap":2822771288},{"date":"2023-07-14","current":19.140259,"twenty":16.955322,"median":21.194819,"eighty":30.374484,"marketCap":3145471956},{"date":"2023-07-21","current":22.272461,"twenty":16.9482,"median":21.240006,"eighty":30.381903,"marketCap":3210797966},{"date":"2023-07-28","current":22.401932,"twenty":16.944638,"median":21.281264,"eighty":30.385612,"marketCap":3229462540},{"date":"2023-08-04","current":21.798869,"twenty":16.944638,"median":21.362879,"eighty":30.385612,"marketCap":3142524917},{"date":"2023-08-11","current":22.605317,"twenty":16.944638,"median":21.393729,"eighty":30.385612,"marketCap":3258782486},{"date":"2023-08-18","current":21.616995,"twenty":16.944638,"median":21.462546,"eighty":30.385612,"marketCap":3116305941},{"date":"2023-08-25","current":21.323906,"twenty":16.944638,"median":21.480607,"eighty":30.385612,"marketCap":3074054276},{"date":"2023-09-01","current":22.213396,"twenty":16.941077,"median":21.556303,"eighty":30.389322,"marketCap":3202283166},{"date":"2023-09-08","current":21.569282,"twenty":16.941077,"median":21.60996,"eighty":30.389322,"marketCap":3109427763},{"date":"2023-09-15","current":21.882819,"twenty":16.941077,"median":21.616127,"eighty":30.389322,"marketCap":3154627219},{"date":"2023-09-22","current":21.061489,"twenty":16.941077,"median":21.621272,"eighty":30.389322,"marketCap":3036224297},{"date":"2023-09-29","current":21.156914,"twenty":16.941077,"median":21.621272,"eighty":30.389322,"marketCap":3049980653},{"date":"2023-10-05","current":20.373072,"twenty":16.941077,"median":21.621272,"eighty":30.389322,"marketCap":2936982014},{"date":"2023-10-13","current":19.302957,"twenty":16.962706,"median":21.62555,"eighty":30.393031,"marketCap":2782714307},{"date":"2023-10-20","current":19.766808,"twenty":17.094797,"median":21.635278,"eighty":30.394386,"marketCap":2603881679},{"date":"2023-10-27","current":19.173804,"twenty":17.14802,"median":21.654483,"eighty":30.398449,"marketCap":2525765228},{"date":"2023-11-03","current":20.624613,"twenty":17.21745,"median":21.654483,"eighty":30.398449,"marketCap":2716880317},{"date":"2023-11-10","current":19.788994,"twenty":17.261187,"median":21.654483,"eighty":30.398449,"marketCap":2606804215},{"date":"2023-11-17","current":21.859285,"twenty":17.306392,"median":21.660629,"eighty":30.398449,"marketCap":2879523600},{"date":"2023-11-24","current":21.113234,"twenty":17.347082,"median":21.667395,"eighty":30.398449,"marketCap":2781246344},{"date":"2023-12-01","current":21.818252,"twenty":17.382449,"median":21.672805,"eighty":30.398449,"marketCap":2874118351},{"date":"2023-12-08","current":23.530438,"twenty":17.431804,"median":21.701465,"eighty":30.398449,"marketCap":3099664654},{"date":"2023-12-15","current":27.555382,"twenty":17.450036,"median":21.745585,"eighty":30.398449,"marketCap":3629870450},{"date":"2023-12-22","current":27.365139,"twenty":17.496342,"median":21.810744,"eighty":30.398449,"marketCap":3604809750},{"date":"2023-12-29","current":28.827398,"twenty":17.527254,"median":21.852697,"eighty":30.399804,"marketCap":3797433171},{"date":"2024-01-05","current":26.820522,"twenty":17.571979,"median":21.883893,"eighty":30.40319,"marketCap":3533067353},{"date":"2024-01-12","current":25.46644,"twenty":17.607846,"median":21.929604,"eighty":30.40319,"marketCap":3354694133},{"date":"2024-01-19","current":24.690547,"twenty":17.644846,"median":21.986315,"eighty":30.406577,"marketCap":3252485787},{"date":"2024-01-26","current":26.760864,"twenty":17.711966,"median":22.045314,"eighty":30.40319,"marketCap":3453462775},{"date":"2024-02-02","current":27.042638,"twenty":17.738956,"median":22.116155,"eighty":30.40319,"marketCap":3489825360},{"date":"2024-02-09","current":26.34582,"twenty":17.7688,"median":22.15546,"eighty":30.40319,"marketCap":3399901671},{"date":"2024-02-16","current":27.141639,"twenty":17.80097,"median":22.213396,"eighty":30.40319,"marketCap":3502601403},{"date":"2024-02-23","current":27.30918,"twenty":17.835673,"median":22.249478,"eighty":30.40319,"marketCap":3524222400},{"date":"2024-03-01","current":28.224884,"twenty":17.840133,"median":22.284274,"eighty":30.399804,"marketCap":3642393114},{"date":"2024-03-08","current":29.072974,"twenty":17.854544,"median":22.345044,"eighty":30.399804,"marketCap":3751838236},{"date":"2024-03-15","current":26.943156,"twenty":17.854544,"median":22.410631,"eighty":30.399804,"marketCap":3476987362},{"date":"2024-03-22","current":29.203449,"twenty":17.862113,"median":22.484099,"eighty":30.399804,"marketCap":3768675948},{"date":"2024-03-28","current":29.116605,"twenty":17.870066,"median":22.523144,"eighty":30.399804,"marketCap":3757468730},{"date":"2024-04-05","current":28.065076,"twenty":17.868475,"median":22.583959,"eighty":30.40319,"marketCap":3621769977},{"date":"2024-04-12","current":27.869353,"twenty":17.868475,"median":22.609066,"eighty":30.40319,"marketCap":3596512181},{"date":"2024-04-19","current":25.6312,"twenty":17.868475,"median":22.695824,"eighty":30.40319,"marketCap":3274103832},{"date":"2024-04-26","current":27.635851,"twenty":17.870066,"median":22.753371,"eighty":30.399804,"marketCap":3530175929},{"date":"2024-05-03","current":27.556733,"twenty":17.870066,"median":22.836196,"eighty":30.399804,"marketCap":3520069499},{"date":"2024-05-10","current":29.163628,"twenty":17.870066,"median":22.943915,"eighty":30.399804,"marketCap":3725332736},{"date":"2024-05-17","current":29.183411,"twenty":17.870066,"median":23.090775,"eighty":30.399804,"marketCap":3727859756},{"date":"2024-05-24","current":28.221973,"twenty":17.870066,"median":23.209747,"eighty":30.399804,"marketCap":3605046589},{"date":"2024-05-31","current":27.054795,"twenty":17.870066,"median":23.285328,"eighty":30.399804,"marketCap":3455952415},{"date":"2024-06-07","current":27.822363,"twenty":17.870066,"median":23.445508,"eighty":30.399804,"marketCap":3554000787},{"date":"2024-06-14","current":28.154712,"twenty":17.868475,"median":23.529127,"eighty":30.40319,"marketCap":3596454721},{"date":"2024-06-21","current":28.269451,"twenty":17.866885,"median":23.600941,"eighty":30.406577,"marketCap":3611111437},{"date":"2024-06-28","current":28.00832,"twenty":17.862113,"median":23.655779,"eighty":30.416736,"marketCap":3577754774},{"date":"2024-07-05","current":28.550365,"twenty":17.862113,"median":23.741772,"eighty":30.416736,"marketCap":3646995119},{"date":"2024-07-12","current":29.808544,"twenty":17.862113,"median":23.829483,"eighty":30.416736,"marketCap":3807713585},{"date":"2024-07-15","current":30.034066,"twenty":17.862113,"median":23.84751,"eighty":30.416736,"marketCap":3836521612},{"date":"2024-08-02","current":33.347515,"twenty":17.848785,"median":23.979228,"eighty":30.525101,"marketCap":4259544743},{"date":"2024-08-09","current":32.935122,"twenty":17.848785,"median":24.052267,"eighty":30.630396,"marketCap":4206869033},{"date":"2024-08-16","current":33.287348,"twenty":17.848785,"median":24.123689,"eighty":30.714063,"marketCap":4251859581},{"date":"2024-08-23","current":33.750387,"twenty":17.848785,"median":24.183737,"eighty":30.826419,"marketCap":4311004459},{"date":"2024-08-30","current":34.755617,"twenty":17.848785,"median":24.299974,"eighty":30.970882,"marketCap":4439404451},{"date":"2024-09-06","current":34.79915,"twenty":17.848785,"median":24.36742,"eighty":31.120432,"marketCap":4444965081},{"date":"2024-09-13","current":35.404663,"twenty":17.848785,"median":24.435486,"eighty":31.286647,"marketCap":4522308383},{"date":"2024-09-20","current":37.834627,"twenty":17.848785,"median":24.535811,"eighty":31.405188,"marketCap":4832692616},{"date":"2024-09-27","current":37.620917,"twenty":17.848785,"median":24.628464,"eighty":31.548301,"marketCap":4805394980},{"date":"2024-10-04","current":36.576111,"twenty":17.848785,"median":24.693686,"eighty":31.671335,"marketCap":4671939870},{"date":"2024-10-11","current":36.342613,"twenty":17.848785,"median":24.776362,"eighty":31.921404,"marketCap":4642114675},{"date":"2024-10-18","current":39.372812,"twenty":17.848785,"median":24.882576,"eighty":32.212468,"marketCap":5325566602},{"date":"2024-10-25","current":37.545256,"twenty":17.848785,"median":25.007411,"eighty":32.383174,"marketCap":5078371341},{"date":"2024-10-31","current":37.732123,"twenty":17.848785,"median":25.038793,"eighty":32.531573,"marketCap":5103646930},{"date":"2024-11-08","current":38.195552,"twenty":17.848309,"median":25.036169,"eighty":32.647241,"marketCap":5166330391},{"date":"2024-11-15","current":37.647327,"twenty":17.848309,"median":25.05345,"eighty":32.844946,"marketCap":5092177385},{"date":"2024-11-22","current":38.12203,"twenty":17.848309,"median":25.05345,"eighty":32.996976,"marketCap":5156385738},{"date":"2024-11-29","current":39.120028,"twenty":17.848309,"median":25.05345,"eighty":33.070314,"marketCap":5291374952},{"date":"2024-12-06","current":37.834218,"twenty":17.848309,"median":25.05345,"eighty":33.177608,"marketCap":5117456264},{"date":"2024-12-13","current":37.6249,"twenty":17.848309,"median":25.05345,"eighty":33.254869,"marketCap":5089143920},{"date":"2024-12-20","current":33.890817,"twenty":17.848309,"median":25.143514,"eighty":33.332395,"marketCap":4584071917},{"date":"2024-12-27","current":35.344829,"twenty":17.848309,"median":25.20584,"eighty":33.433016,"marketCap":4780741596},{"date":"2025-01-03","current":34.152464,"twenty":17.848309,"median":25.316828,"eighty":33.484887,"marketCap":4619462348},{"date":"2025-01-10","current":33.449754,"twenty":17.847833,"median":25.412351,"eighty":33.512931,"marketCap":4524413763},{"date":"2025-01-17","current":32.918984,"twenty":17.847833,"median":25.627156,"eighty":33.512931,"marketCap":4452621747},{"date":"2025-01-24","current":29.843666,"twenty":17.847833,"median":25.682916,"eighty":33.512931,"marketCap":4514302211},{"date":"2025-01-31","current":29.689919,"twenty":17.847833,"median":25.682916,"eighty":33.512931,"marketCap":4491045643},{"date":"2025-02-07","current":29.850351,"twenty":17.847833,"median":25.682916,"eighty":33.512931,"marketCap":4515313366},{"date":"2025-02-14","current":28.209267,"twenty":17.847833,"median":25.682916,"eighty":33.512931,"marketCap":4267074775},{"date":"2025-02-21","current":28.924526,"twenty":17.847833,"median":25.682916,"eighty":33.512931,"marketCap":4375268377},{"date":"2025-02-28","current":29.116429,"twenty":17.847833,"median":25.724336,"eighty":33.512931,"marketCap":4404296702},{"date":"2025-03-07","current":28.988386,"twenty":17.846293,"median":25.852331,"eighty":33.522419,"marketCap":4384928194},{"date":"2025-03-14","current":25.446971,"twenty":17.849737,"median":25.966294,"eighty":33.522419,"marketCap":3849236048},{"date":"2025-03-21","current":26.589254,"twenty":17.892782,"median":26.105931,"eighty":33.522419,"marketCap":4022023524},{"date":"2025-03-28","current":26.946428,"twenty":17.939383,"median":26.181536,"eighty":33.522419,"marketCap":4076051467},{"date":"2025-04-04","current":25.986102,"twenty":17.978554,"median":26.303934,"eighty":33.522419,"marketCap":3930787659},{"date":"2025-04-11","current":24.851655,"twenty":18.014155,"median":26.294159,"eighty":33.512931,"marketCap":3759185663},{"date":"2025-04-17","current":23.983353,"twenty":18.072738,"median":26.294159,"eighty":33.512931,"marketCap":3766321745},{"date":"2025-04-25","current":24.944115,"twenty":18.128761,"median":26.303934,"eighty":33.522419,"marketCap":3917198891},{"date":"2025-05-02","current":24.905165,"twenty":18.128761,"median":26.303934,"eighty":33.522419,"marketCap":3911082250},{"date":"2025-05-05","current":25.470263,"twenty":18.128761,"median":26.303934,"eighty":33.522419,"marketCap":3999824658}],"updateTime":1746583422825}}}